Guru Ownership Trend
Guru Analysis for Arbutus Biopharma Corporation (ABUS)
Arbutus Biopharma Corporation (ABUS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9.07 M.
Top institutional holders include Jefferies Group and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $915,415.14 net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 33.3%. Conversely, Jefferies Group reduced exposure by 9.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Arbutus Biopharma Corporation (ABUS)
Major holders include Jefferies Group ($8.22 M), Cliff Asness ($152,358). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.74 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $915,415.14, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited ABUS. The total reported sell value was $953,441.04.
Yes, 0 managers opened new positions in ABUS, and 1 increased their existing holdings. The total reported buy value was $38,025.9.